Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Neuroscience and Biobehavioral Reviews|October 21, 2025
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literatureAlessio Mosca, Gianluca Mancusi, Stefania Chiappini, et al.International Journal of Impotence Research|May 5, 2022
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databasesNicolò Schifano, Paolo Capogrosso, Luca Boeri, et al.Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World StudyStefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 21, 2023
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study GroupGiacomo d'Andrea, Stefania Chiappini, Roger S McIntyre, et al.Journal of Clinical Medicine|April 27, 2024
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World InvestigationClara Cavallotto, Stefania Chiappini, Alessio Mosca, et al.Actas Espanolas De Psiquiatria|January 13, 2025
Alcohol Use Disorders and Suicidal Behaviour: A Narrative ReviewMatteo Lupi, Stefania Chiappini, Alessio Mosca, et al.Addictive Behaviors|July 20, 2026
Prefrontal transcranial direct current stimulation in alcohol use disorder: a pilot randomized sham-controlled trial with exploratory effects on reward craving and depressive symptomsAndrea Miuli, Stefania Chiappini, Clara Cavallotto, et al.Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World StudyAlessio Mosca, Clara Cavallotto, Stefania Chiappini, et al.European Addiction Research|June 5, 2023
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young AdultsFrancesco Di Carlo, Valeria Verrastro, Maria Chiara Alessi, et al.Translational Psychiatry|November 1, 2025
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changesGiacomo d'Andrea, Stefania Chiappini, Laura Ciavoni, et al.Pageof 9